History and previous editions
From an idea to a growing RNA community.
The Swiss RNA Therapeutics Summit connects experts from academia, biotechnology, pharma, manufacturing, government and regulatory bodies—creating space for scientific exchange, new collaborations and future talent.
What began as a shared vision has developed into one of Switzerland’s key meeting points for the RNA therapeutics community.
The idea takes shape
The concept emerged following the panel discussion “RNA Drugs: Applications Beyond Vaccines” at Swiss Biotech Day in Basel. The inaugural Summit was launched as a joint initiative of the NCCR RNA & Disease and the Swiss Biotech Association.
Previous editions
Explore the programs, speakers and partners that shaped the first three editions of the Swiss RNA Therapeutics Summit.
The Summit begins
The inaugural edition brought Switzerland’s RNA therapeutics ecosystem together for a full day of science, industry exchange and networking.
A fully booked return
The second Summit expanded the community and strengthened connections across academic research, biotechnology and pharmaceutical development.
The community grows
The third edition continued the Summit’s momentum with leading voices in RNA medicine, translational science and therapeutic development.
The story continues in 2027.
The fourth Swiss RNA Therapeutics Summit is powered by the Swiss Initiative for RNA & Disease (SIRD), connecting a new chapter with the community built over the previous editions.
Origin of the Summit
The Swiss RNA Therapeutics Summit connects experts from academia, biotechnology, pharma, manufacturing, government and regulatory bodies to drive exchange and collaboration across the rapidly evolving RNA therapeutics landscape. It also creates opportunities for companies to engage with early-career researchers and future professionals.
First Swiss RNA Therapeutics Summit – January 2023
The first Swiss RNA Therapeutics Summit took place on 26 January 2023 at the University of Bern and was co-organised with the Swiss Biotech Association.
The event brought together more than 180 participants from academia, industry and other sectors.
The programme featured opening remarks by Christian Leumann, Rector of the University of Bern and an expert in oligonucleotide chemistry, as well as keynote lectures by Mustafa Diken, Vice President of Vaccines & Immunology at BioNTech, and Shalini Andersson, Vice President of Oligonucleotide Discovery at AstraZeneca. Panel discussions and company presentations complemented the scientific programme.
The inaugural Summit was made possible through the collective support and commitment of its sponsors, partners, speakers, organisers and participants.
Click here to see the Program, Speakers List and Sponsors of the 2023 Edition
Second Swiss RNA Therapeutics Summit – January 2024
The second Swiss RNA Therapeutics Summit took place on 25 January 2024 in Bern and was fully booked, welcoming more than 200 registered participants. Opening remarks were delivered by Hugues Abriel, Vice-Rector for Research at the University of Bern.
The keynote programme featured Paul Nioi, Senior Vice President of Research at Alnylam Pharmaceuticals, speaking on siRNA therapies for neurological diseases, and Martin Jinek, Professor at the University of Zurich and co-discoverer of CRISPR, presenting on CRISPR genome editing.
The success of the second Summit reflected the dedication and valuable contributions of its sponsors, partners, speakers, organisers and participants.
Click here to see Program, Speakers List, and Sponsor of the 2024 Edition
Third Swiss RNA Therapeutics Summit – January 2025
The third Swiss RNA Therapeutics Summit took place on 30 January 2025 in Bern.
The success of the second Summit reflected the dedication and valuable contributions of its sponsors, partners, speakers, organisers and participants.
Click here to see Program, Speakers List, and Sponsor of the 2025 Edition
Let’s keep the conversation going.
Have a question about the Summit, registration or sponsorship? Get in touch with the RNATX team or follow us for the latest program announcements.